Bleeding Disorders in Adolescents

Obstetrics and Gynecology Clinics of North America

Volumn 36, Issue 1, 2009, Pages 153-162

  James, Andra H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adolescent; Bleeding disorder; Hemorrhagic ovarian cyst; Menorrhagia; Von Willebrand disease

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 9; CONJUGATED ESTROGEN; DESMOPRESSIN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; FRESH FROZEN PLASMA; GESTAGEN; LEUPRORELIN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ADOLESCENT; BALLOON CATHETER; BERNARD SOULIER DISEASE; BLEEDING DISORDER; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL PRACTICE; CRYOPRECIPITATE; CURETTAGE; DRUG TOLERABILITY; ENDOMETRIOSIS; FIBRINOLYSIS; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMOPHILIA; HEMOSTASIS; HORMONAL THERAPY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; OVARIECTOMY; OVARY CYST; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SCREENING; SENSITIVITY ANALYSIS; SIDE EFFECT; THROMBIN TIME; THROMBOCYTE DYSFUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

ADOLESCENT; BLOOD COAGULATION DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOSTATIC TECHNIQUES; HUMANS; MENORRHAGIA; PROGNOSIS; RISK FACTORS;

EID: 63149171240     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2008.12.002     Document Type: Review

References (59)

1. Nichols W., Hultin M., James A., et al. The diagnosis, evaluation and management of von Willebrand disease (2007), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda (MD)
2. Roberts H., and Escobar M. Other clotting factor deficiencies. In: Hoffman R. (Ed). Hematology: basic principles and practice. 4th edition (2005), Churchill Livingstone, New York
3. James A.H. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 11 4 (2005) 295-307
4. Kirtava A., Drews C., Lally C., et al. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 9 3 (2003) 292-297
5. Sramek A., Eikenboom J.C., Briet E., et al. Usefulness of patient interview in bleeding disorders. Arch Intern Med 155 13 (1995) 1409-1415
6. Lopez J.A., Andrews R.K., Afshar-Kharghan V., et al. Bernard-Soulier syndrome. Blood 91 12 (1998) 4397-4418
7. George J.N., Caen J.P., and Nurden A.T. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 75 7 (1990) 1383-1395
8. Kadir R.A., Economides D.L., and Lee C.A. Factor XI deficiency in women. Am J Hematol 60 1 (1999) 48-54
9. Kadir R.A., Economides D.L., Sabin C.A., et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 5 1 (1999) 40-48
10. Mauser Bunschoten E.P., van Houwelingen J.C., Sjamsoedin Visser E.J., et al. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 59 3 (1988) 349-352
11. Greer I.A., Lowe G.D., Walker J.J., et al. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 98 9 (1991) 909-918
12. Yang J., Hartmann K.E., Savitz D.A., et al. Vaginal bleeding during pregnancy and preterm birth. Am J Epidemiol 160 2 (2004) 118-125
13. Burrows R.F., Ray J.G., and Burrows E.A. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv 55 2 (2000) 103-108
14. Lak M., Keihani M., Elahi F., et al. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 107 1 (1999) 204-206
15. Lak M., Peyvandi F., Ali Sharifian A., et al. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 1 8 (2003) 1852-1853
16. Shetty S., Madkaikar M., Nair S., et al. Combined factor V and VIII deficiency in Indian population. Haemophilia 6 5 (2000) 504-507
17. James A., Matchar D.B., and Myers E.R. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet Gynecol 104 2 (2004) 381-388
18. Philipp C.S., Faiz A., Dowling N., et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 105 1 (2005) 61-66
19. ACOG. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign (2006), American College of Obstetricians and Gynecologists, Washington, DC
20. ACOG. Management of anovulatory bleeding (2000), American College of Obstetricians and Gynecologists, Washington, DC
21. Hallberg L., Hogdahl A.M., Nilsson L., et al. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 45 3 (1966) 320-351
22. Hallberg L., Hogdahl A.M., Nilsson L., et al. Menstrual blood loss and iron deficiency. Acta Med Scand 180 5 (1966) 639-650
23. Warner P.E., Critchley H.O., Lumsden M.A., et al. Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia?. Am J Obstet Gynecol 190 5 (2004) 1224-1229
24. Higham J.M., O'Brien P.M., and Shaw R.W. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97 8 (1990) 734-739
25. Janssen C.A., Scholten P.C., and Heintz A.P. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 85 6 (1995) 977-982
26. Reid P.C., Coker A., and Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG 107 3 (2000) 320-322
27. Warner P.E., Critchley H.O., Lumsden M.A., et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 190 5 (2004) 1216-1223
28. Philipp C.S., Faiz A., Dowling N.F., et al. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Am J Obstet Gynecol 198 2 (2008) 163 e161-8
29. Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 238 (1973) 1-159
30. Gomez A., Lucia J.F., Perella M., et al. Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease. Haemophilia 4 1 (1998) 60-62
31. Jarvis R.R., and Olsen M.E. Type I von Willebrand's disease presenting as recurrent corpus hemorrhagicum. Obstet Gynecol 99 5 Pt 2 (2002) 887-888
32. Ghosh K., Mohanty D., Pathare A.V., et al. Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive. Haemophilia 4 5 (1998) 767-768
33. Bottini E., Pareti F.I., Mari D., et al. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports. Haematologica 76 5 (1991) 431-433
34. Lobo R.A. Endometriosis: etiology, pathology, diagnosis, management. In: Katz V., Lentz G., Lobo R., et al. (Eds). Katz: comprehensive gynecology. 5th edition (2007), Mosby, Philadelphia 473-495
35. Vercellini P., De Giorgi O., Aimi G., et al. Menstrual characteristics in women with and without endometriosis. Obstet Gynecol 90 2 (1997) 264-268
36. Foster P.A. The reproductive health of women with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 74 2 (1995) 784-790
37. Beller F.K., and Ebert C. Effects of oral contraceptives on blood coagulation. A review. Obstet Gynecol Surv 40 7 (1985) 425-436
38. Kadir R.A., Economides D.L., Sabin C.A., et al. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 82 5 (1999) 1456-1461
39. Middeldorp S., Meijers J.C., van den Ende A.E., et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost 84 1 (2000) 4-8
40. Kingman C.E., Kadir R.A., Lee C.A., et al. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. BJOG 111 12 (2004) 1425-1428
41. Edelman A.B., Koontz S.L., Nichols M.D., et al. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?. Obstet Gynecol 107 3 (2006) 657-665
42. Amesse L.S., Pfaff-Amesse T., Leonardi R., et al. Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study. J Pediatr Hematol Oncol 27 7 (2005) 357-363
43. Kouides PA, Heit JA, Philipp CS, et al. A multi-site, prospective, cross-over study of intranasal desmopressin and oral tranexamic acid in women with menorrhagia and abnormal laboratory hemostasis. Blood 2007;110:711 [ASH Annual Meeting Abstracts].
44. Ozelo M.C., Svirin P., and Larina L. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome. Ann Hematol 84 12 (2005) 816-822
45. Levens E.D., Scheinberg P., and DeCherney A.H. Severe menorrhagia associated with thrombocytopenia. Obstet Gynecol 110 4 (2007) 913-917
46. DeVore G.R., Owens O., and Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding-a double-blind randomized control study. Obstet Gynecol 59 3 (1982) 285-291
47. Livio M., Mannucci P.M., Vigano G., et al. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315 12 (1986) 731-735
48. Lobo R.A. Abnormal uterine bleeding. In: Katz V., Lentz G., Lobo R., et al. (Eds). Katz: comprehensive gynecology. 5th edition (2007), Mosby, Philadelphia 915-929
49. Laufer M.R., Townsend N.L., Parsons K.E., et al. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate. J Reprod Med 42 9 (1997) 537-541
50. Amsterdam A., Jakubowski A., Castro-Malaspina H., et al. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 34 4 (2004) 363-366
51. Rouhani G., Menon S., Burgis J., et al. An unusual method to manage a rare blood dyscrasia. J Pediatr Adolesc Gynecol 20 2 (2003) S123-S124
52. Bowkley C.W., Dubel G.J., Haas R.A., et al. Uterine artery embolization for control of life-threatening hemorrhage at menarche: brief report. J Vasc Interv Radiol 18 1 Pt 1 (2007) 127-131
53. Markovitch O., Ellis M., Holzinger M., et al. Severe juvenile vaginal bleeding due to Glanzmann's thrombasthenia: case report and review of the literature. Am J Hematol 57 3 (1998) 225-227
54. Claessens E.A., and Cowell C.A. Acute adolescent menorrhagia. Am J Obstet Gynecol 139 3 (1981) 277-280
55. Smith Y.R., Quint E.H., and Hertzberg R.B. Menorrhagia in adolescents requiring hospitalization. J Pediatr Adolesc Gynecol 11 1 (1998) 13-15
56. Oral E., Cagdas A., Gezer A., et al. Hematological abnormalities in adolescent menorrhagia. Arch Gynecol Obstet 266 2 (2002) 72-74
57. Bevan J.A., Maloney K.W., Hillery C.A., et al. Bleeding disorders: a common cause of menorrhagia in adolescents. J Pediatr 138 6 (2001) 856-861
58. Jayasinghe Y., Moore P., Donath S., et al. Bleeding disorders in teenagers presenting with menorrhagia. Aust N Z J Obstet Gynaecol 45 5 (2005) 439-443
59. Mikhail S., Varadarajan R., and Kouides P. The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre. Haemophilia 13 5 (2007) 627-632